S&P 500
7,596.71
+16.64
+0.22%
Dow
52,254.46
+484.15
+0.94%
Nasdaq
25,452.52
+15.52
+0.06%
NYSE Composite
24,466.59
+173.50
+0.71%
Russell 2000
2,825.72
+13.88
+0.49%
VIX
19.72
+0.30
+1.54%
TEM · Tempus AI, Inc. Class A
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Tempus AI, Inc. (TEM)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$78.99
+6.77
(+9.37%)
● Market open
DAY'S RANGE
$78.99
$70.62
$83.42
52-WEEK RANGE
$78.99
$40.77
$91.83
What's happening
- TEM is up 9.37% today, trading at $78.99. — Live quote
- Volume today (737,083) is well below its 3-month average of 6,545,500. (Finnhub fundamentals)
- Reports earnings on 2026-11-02 (before market open), 0 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.04 actual vs. $-0.14 estimated (+71.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 9
Hold 12
Sell 0
Strong sell 1
Aggregate ratings for 2026-11-01 (27 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TEM
+22.30%
vs S&P 500
+11.48%
1-YEAR RETURN
TEM
-16.29%
vs S&P 500
-27.45%
6-MONTH RETURN
TEM
+41.33%
3-MONTH RETURN
TEM
+64.62%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.04
Est. $-0.14
BEAT +71.7%
2026-04-26 (Q1 2026)
$-0.13
Est. $-0.19
BEAT +32.8%
2026-01-26 (Q4 2025)
$-0.04
Est. $-0.04
BEAT +5.2%
2025-10-26 (Q3 2025)
$-0.11
Est. $-0.17
BEAT +35.1%
Valuation Measures & Ratios
Enterprise Value4$13.92B
Forward P/E5—
PEG Ratio6-2.50
Price / Sales (TTM1)9.19
Price / Book723.38
EV4 / Revenue9.72
EV4 / EBITDA—
Profit Margin-17.77%
Operating Margin-21.42%
Return on Equity (ROE8)-54.70%
Return on Assets (ROA9)-11.24%
Avg Volume (3M)6,545,500
Quarterly history (5 periods)
| Measure | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $15.19B | $10.89B | $8.02B | $14.03B | $10.88B |
| P/E | -70.62 | -44.79 | -25.31 | -52.61 | -14.73 |
| Price/Sales | 10.29 | 7.89 | 6.40 | 12.93 | 11.87 |
| Price/Book | 30.36 | 24.47 | 19.26 | 27.63 | 35.16 |
| EV/Revenue | 9.89 | 7.46 | 5.98 | 12.32 | 11.66 |
| ROE | -42.99% | -54.64% | -76.08% | -52.52% | -238.70% |
| ROA | -8.77% | -10.28% | -14.84% | -11.69% | -45.46% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short25,375,199
Change from Prior Settlement+1.02%
% of Float—
Days to Cover (Short Ratio)3.55
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 21.6% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-11-02; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -17.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -16.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TEM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $411.5M | $382.5M | $348.1M | $334.2M | $314.6M | $255.7M | $180.9M | $166.0M |
| Operating income | -$56.9M | -$75.9M | -$84.7M | -$61.0M | -$61.8M | -$68.7M | -$53.6M | -$533.5M |
| Net income | -$14.9M | $5.6M | -$125.9M | -$80.0M | -$42.8M | -$68.0M | -$75.8M | -$552.2M |
| EPS (diluted) | $-0.08 | $0.03 | $-0.71 | $-0.46 | $-0.25 | $-0.40 | $-0.46 | $-6.86 |
| EPS (basic) | $-0.08 | $0.03 | $-0.70 | $-0.46 | $-0.25 | $-0.40 | $-0.46 | $-6.86 |
| Operating margin | -$14 | -$20 | -$24 | -$18 | -$20 | -$27 | -$30 | -$321 |
| Net margin | -$4 | $1 | -$36 | -$24 | -$14 | -$27 | -$42 | -$333 |
Balance sheet
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.45B | $2.37B | $2.14B | $2.27B | $2.28B | $1.63B | $1.54B | $926.1M |
| Total liabilities | $1.95B | $1.92B | $1.72B | $1.78B | $1.77B | $1.32B | $1.22B | $869.8M |
| Stockholders' equity | $500.4M | $444.9M | $416.4M | $491.3M | $507.8M | $309.6M | $326.2M | $56.3M |
| Total current assets | $1.14B | $1.29B | $1.05B | $1.17B | $1.15B | $644.2M | $574.0M | $667.6M |
| Total current liabilities | $436.4M | $391.5M | $318.0M | $372.4M | $350.0M | $418.2M | $336.5M | $291.1M |
| Cash & equivalents | $590.5M | $599.6M | $521.2M | $604.8M | $655.9M | $186.3M | $151.6M | $341.0M |
| Accounts receivable | $380.7M | $360.9M | $308.6M | $311.2M | $283.6M | $266.3M | $262.6M | $154.8M |
| Inventory | $53.8M | $53.5M | $51.8M | $51.7M | $55.0M | $47.6M | $50.5M | $38.4M |
| Property, plant & equipment | $95.2M | $89.1M | $88.6M | $89.2M | $90.7M | $92.6M | $93.5M | $58.1M |
| Goodwill | $488.1M | $470.2M | $470.2M | $470.2M | $465.1M | $325.8M | $325.8M | $73.3M |
| Intangible assets | $293.8M | $312.5M | $330.6M | $349.2M | $372.9M | $387.6M | $399.5M | $11.7M |
| Accounts payable | $70.5M | $73.8M | $41.0M | $82.0M | $59.6M | $79.3M | $88.7M | $53.8M |
| Accrued liabilities | $233.0M | $181.3M | $160.6M | $155.4M | $160.8M | $165.9M | $129.2M | $130.4M |
| Deferred revenue (current) | $85.9M | $87.3M | $72.9M | $92.7M | $84.7M | $100.5M | $73.4M | $76.0M |
| Other current liabilities | $12.1M | $8.3M | $10.2M | $8.7M | $11.8M | $16.6M | $18.2M | $7.0M |
| Other non-current liabilities | $51.4M | $56.3M | $54.1M | $56.6M | $58.8M | $9.5M | $9.7M | $16.0M |
| Retained earnings | -$2.53B | -$2.52B | -$2.52B | -$2.40B | -$2.34B | -$2.26B | -$2.22B | -$2.15B |
| Accumulated other comprehensive income (loss) | $166.0K | -$1.9M | -$908.0K | $902.0K | $5.5M | $8.4M | $4.7M | $94.0K |
Cash flow
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.2M | -$7.5M | -$73.3M | -$36.8M | -$119.8M | $44.2M | -$105.6M | -$39.3M |
| Investing cash flow | -$17.5M | -$11.1M | -$10.1M | -$10.7M | -$2.3M | -$9.5M | -$375.8M | -$8.0M |
| Financing cash flow | -$715.0K | $97.1M | -$271.0K | -$3.6M | $594.7M | $0 | $293.0M | -$179.0K |
| Free cash flow | -$122.0K | -$13.7M | -$81.5M | -$41.5M | -$126.5M | $36.6M | -$107.7M | -$47.2M |
| Capital expenditures | $9.3M | $6.1M | $8.2M | $4.8M | $6.7M | $7.5M | $2.1M | $8.0M |
| Share-based compensation | $48.1M | $54.1M | $52.7M | $45.3M | $34.0M | $22.5M | $23.0M | $24.8M |
| Deferred income taxes | $0 | $0 | $0 | -$6.4M | $0 | $0 | -$46.2M | $0 |
| Change in accounts receivable | $21.3M | $52.6M | -$2.0M | $27.2M | $14.0M | $4.0M | $45.2M | $9.3M |
| Change in inventory | -$28.0K | $1.9M | $332.0K | -$3.2M | $8.5M | -$2.9M | $911.0K | $2.2M |
| Change in accounts payable | -$19.0M | $20.3M | -$50.6M | $11.3M | -$25.6M | -$16.5M | $23.6M | $924.0K |
| Purchases of investments | — | — | — | $2.7M | $0 | — | — | $0 |
| Dividends paid | — | — | — | $0 | $0 | $0 | — | $0 |
| Debt repaid | $0 | $207.7M | — | $0 | $276.9M | $0 | — | $0 |
| Tax withholding on stock comp | — | — | — | $0 | $0 | $0 | — | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Revenue | $1.27B | $693.4M | $531.8M | $320.7M |
| Operating income | -$252.9M | -$691.1M | -$196.1M | -$265.4M |
| Net income | -$245.0M | -$705.8M | -$214.1M | -$289.8M |
| EPS (diluted) | $-1.41 | $-6.23 | $-4.20 | $-5.30 |
| EPS (basic) | $-1.41 | $-6.23 | $-4.20 | $-5.30 |
| Operating margin | -$20 | -$100 | -$37 | -$83 |
| Net margin | -$19 | -$102 | -$40 | -$90 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.27B | $926.1M | $564.1M | — | — |
| Total liabilities | $1.78B | $869.8M | $840.7M | — | — |
| Stockholders' equity | $491.3M | $56.3M | -$1.38B | -$1.13B | -$807.5M |
| Total current assets | $1.17B | $667.6M | $350.3M | — | — |
| Total current liabilities | $372.4M | $291.1M | $232.6M | — | — |
| Cash & equivalents | $604.8M | $341.0M | $165.8M | $302.9M | — |
| Accounts receivable | $311.2M | $154.8M | $94.5M | — | — |
| Inventory | $51.7M | $38.4M | $28.8M | — | — |
| Property, plant & equipment | $89.2M | $58.1M | $61.7M | — | — |
| Goodwill | $470.2M | $73.3M | $73.4M | $53.1M | — |
| Intangible assets | $355.3M | $11.7M | $21.9M | — | — |
| Accounts payable | $82.0M | $53.8M | $54.4M | — | — |
| Accrued liabilities | $155.4M | $130.4M | $82.5M | — | — |
| Deferred revenue (current) | $92.7M | $76.0M | $64.9M | — | — |
| Other current liabilities | $8.7M | $7.0M | $8.2M | — | — |
| Other non-current liabilities | $56.6M | $16.0M | $19.8M | — | — |
| Retained earnings | -$2.40B | -$2.15B | -$1.40B | — | — |
| Accumulated other comprehensive income (loss) | $902.0K | $94.0K | $5.0K | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating cash flow | -$218.1M | -$189.0M | -$214.3M | -$168.2M |
| Investing cash flow | -$398.4M | -$130.4M | -$40.3M | -$57.9M |
| Financing cash flow | $884.1M | $494.3M | $117.5M | $251.4M |
| Free cash flow | -$239.1M | -$211.2M | -$248.9M | -$186.6M |
| Capital expenditures | $21.0M | $22.1M | $34.6M | $18.4M |
| Share-based compensation | $124.7M | $534.1M | $0 | $0 |
| Deferred income taxes | -$52.7M | $0 | $0 | — |
| Change in accounts receivable | $90.4M | $61.0M | $7.3M | $8.2M |
| Change in inventory | $3.4M | $9.5M | $6.6M | $1.3M |
| Change in accounts payable | -$7.2M | -$23.9M | -$23.4M | -$7.9M |
| Purchases of investments | $2.7M | $36.2M | $0 | $0 |
| Dividends paid | $0 | $5.6M | $5.6M | $5.6M |
| Debt repaid | $276.9M | $0 | $0 | — |
| Tax withholding on stock comp | $0 | $69.9M | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TEM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers51.4%
Shares Outstanding180,243,866
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 10,022,634 | $580.6M | 5.56% | +4.3% | 2026-08-14 |
| BlackRock, Inc. | 8,291,053 | $480.3M | 4.60% | -7.6% | 2026-08-07 |
| BAILLIE GIFFORD & CO | 8,190,133 | $474.5M | 4.54% | -5.3% | 2026-08-06 |
| Softbank Group Corp. | 5,405,406 | $313.1M | 3.00% | +0.0% | 2026-08-14 |
| Jpmorgan Chase & Co | 4,989,062 | $291.2M | 2.77% | +1.1% | 2026-08-12 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,988,038 | $289.0M | 2.77% | +1.4% | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,914,410 | $284.7M | 2.73% | +5.0% | 2026-06-30 |
| Sumitomo Mitsui Trust Group, Inc. | 4,089,029 | $236.9M | 2.27% | -5.5% | 2026-07-30 |
| Amova Asset Management Americas, Inc. | 4,089,029 | $236.6M | 2.27% | -5.5% | 2026-08-13 |
| Goldman Sachs Group Inc | 3,761,666 | $217.9M | 2.09% | +194.4% | 2026-08-14 |
| Morgan Stanley | 3,652,136 | $211.6M | 2.03% | +75.3% | 2026-08-11 |
| Franklin Templeton Inc | 3,352,768 | $194.2M | 1.86% | +29.9% | 2026-08-04 |
| UBS Group AG | 2,546,634 | $147.5M | 1.41% | -21.3% | 2026-08-13 |
| CITADEL ADVISORS LLC | 2,512,401 | $145.5M | 1.39% | +317.8% | 2026-08-14 |
| GC Wealth Management RIA, LLC | 2,411,368 | $139.7M | 1.34% | -63.5% | 2026-07-16 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,092,519 | $121.2M | 1.16% | +7.9% | 2026-08-12 |
| Bank Of America Corp /De/ | 1,917,772 | $111.1M | 1.06% | +362.4% | 2026-08-14 |
| State Street Corp | 1,887,599 | $109.3M | 1.05% | +11.7% | 2026-08-07 |
| Alphabet Inc. | 1,551,102 | $89.9M | 0.86% | +0.0% | 2026-08-06 |
| JANE STREET GROUP, LLC | 1,428,847 | $82.8M | 0.79% | +113.6% | 2026-08-14 |
| Lingotto Investment Management LLP | 1,415,766 | $82.0M | 0.79% | +0.0% | 2026-07-29 |
| Clear Street Group Inc. | 1,345,069 | $77.9M | 0.75% | +40.8% | 2026-08-04 |
| Legal & General Group Plc | 1,145,900 | $66.4M | 0.64% | +48.6% | 2026-08-14 |
| NORGES BANK | 975,302 | $56.5M | 0.54% | +0.0% | 2026-08-12 |
| BAMCO INC /NY/ | 904,259 | $52.4M | 0.50% | +0.6% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-08-03 to 2026-10-27
Recent transactions
- Insiders have net sold 1,322,208 shares over the last 182 days, across 0 purchases and 108 sales.
- Most recent: LEFKOFSKY ERIC P (CEO and Chairman) — Open market sale of 10,428 shares on 2026-10-27.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)1,322,208 sh(108 txns)
Net Shares-1,322,208
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 2026-10-27 | 10,428 |
| Schoenherr Thomas Edward | CEO, Diagnostics | Open market sale | 2026-09-25 | 10,281 |
| Bartolucci Ryan M | Chief Accounting Officer | Open market sale | 2026-09-17 | 7,062 |
| Polovin Andrew | EVP, Chief Legal Officer | Open market sale | 2026-09-17 | 2,951 |
| Fukushima Ryan | CEO, Data | Open market sale | 2026-09-16 | 700 |
| Doudna Jennifer A | Reporting person | Open market sale | 2026-09-01 | 676 |
| Epstein David R | Reporting person | Open market sale | 2026-09-01 | 250 |
| West Nadja | Reporting person | Open market sale | 2026-08-28 | 3,000 |
| Rogers James William | Chief Financial Officer | Open market sale | 2026-08-19 | 26,313 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 10,428 | $67.36 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 7,592 | $68.00 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 1,495 | $69.28 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 6,312 | $70.58 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 16,414 | $71.56 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 15,259 | $72.31 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 24,597 | $67.36 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 17,825 | $68.00 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 3,510 | $69.28 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 14,820 | $70.58 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 38,489 | $71.56 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 35,759 | $72.31 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 1,282 | $67.36 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 961 | $68.00 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 195 | $69.28 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 824 | $70.58 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 2,167 | $71.56 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 2,071 | $72.31 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 9,132 | $67.36 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 6,636 | $68.00 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 1,300 | $69.28 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 5,486 | $70.58 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 14,237 | $71.56 |
| 2026-10-27 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 13,209 | $72.31 |
| 2026-09-25 | Schoenherr Thomas Edward | CEO, Diagnostics | Open market sale | 10,281 | $85.00 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 7,394 | $76.57 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 33,770 | $77.29 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 16,152 | $78.23 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 184 | $78.86 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 17,359 | $76.57 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 79,259 | $77.29 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 37,950 | $78.23 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 432 | $78.86 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 965 | $76.57 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 4,420 | $77.29 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 2,091 | $78.23 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 24 | $78.86 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 6,431 | $76.57 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 29,367 | $77.29 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 14,042 | $78.23 |
| 2026-09-22 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 160 | $78.86 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 52,558 | $80.52 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 4,942 | $81.09 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 123,391 | $80.52 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 11,609 | $81.09 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 6,855 | $80.52 |
| 2026-09-17 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 645 | $81.09 |
| 2026-09-17 | Bartolucci Ryan M | Chief Accounting Officer | Open market sale | 7,062 | $75.00 |
| 2026-09-17 | Polovin Andrew | EVP, Chief Legal Officer | Open market sale | 2,951 | $75.00 |
| 2026-09-16 | Fukushima Ryan | CEO, Data | Open market sale | 700 | $70.00 |
| 2026-09-01 | Fukushima Ryan | CEO, Data | Open market sale | 13,046 | $62.12 |
| 2026-09-01 | Fukushima Ryan | CEO, Data | Open market sale | 10,900 | $62.64 |
| 2026-09-01 | Fukushima Ryan | CEO, Data | Open market sale | 5,900 | $63.80 |
| 2026-09-01 | Fukushima Ryan | CEO, Data | Open market sale | 1,000 | $64.63 |
| 2026-09-01 | Doudna Jennifer A | Reporting person | Open market sale | 676 | $65.55 |
| 2026-09-01 | Epstein David R | Reporting person | Open market sale | 250 | $65.55 |
| 2026-08-28 | West Nadja | Reporting person | Open market sale | 3,000 | $69.00 |
| 2026-08-25 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 11,167 | $69.83 |
| 2026-08-25 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 681 | $70.58 |
| 2026-08-25 | LEFKOFSKY ERIC P | CEO and Chairman | Open market sale | 760 | $64.03 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-02 13:06 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-11-02 | 10-Q | 2026-09-30 | View on SEC.gov → |
| 2026-11-02 | 8-K | 2026-11-02 | View on SEC.gov → |
| 2026-10-29 | 4 | 2026-10-27 | View on SEC.gov → |
| 2026-10-23 | 8-K | 2026-10-23 | View on SEC.gov → |
| 2026-09-29 | 4 | 2026-09-25 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
Recent news
Headlines about TEM (Tempus AI, Inc. Class A). Links open the publisher — we don’t host full articles.
-
Tempus projects $1.60B-$1.605B 2026 revenue while targeting $65M adjusted EBITDA, backed by BMS collaboration
Seeking Alpha · 2026-11-02 -
Tempus AI, Inc. (TEM) Q3 2026 Earnings Call Transcript
Seeking Alpha · 2026-11-02 -
Needham & Company LLC Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock
MarketBeat · 2026-11-02 -
Tempus AI Says It Is Uniquely Positioned
Benzinga · 2026-11-02 -
Tempus AI Soars 10% on Q3 Beat and Raised Guidance as Oncology Sees “Accelerating Unit Growth”
Yahoo Finance · 2026-11-02 -
Tempus (TEM) Q3 2026 Earnings Call Transcript
Yahoo Finance · 2026-11-02 -
TEM Stock Jumps As Tempus AI Lands Big Pharma Data Deals
Timothy Sykes · 2026-11-02 -
Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction
Yahoo Finance · 2026-11-02
No headlines in this category right now — try “All”.